NGL Fine Chem Limited, engaged in manufacturing and exporting APIs, intermediates, and formulations for the veterinary and human health sectors worldwide, hit a 20% upper circuit at ₹2,188.25 after reporting Q3 FY26 results, with 43.11% YoY revenue growth to ₹127.51 crore and a 1,135.43% YoY net profit surge to ₹15.69 crore from ₹1.27 crore.